13 results

e11 LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
Haruko Kunitomi, Yusuke Kobayashi, Ren-Chin Wu, Takashi Takeda, Eiichiro Tominaga, Kouji Banno, Daisuke Aoki
J Gynecol Oncol. 2020;31(2):e11.  Published online 2019 August 21    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e11
e12 Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis
Xiaofeng Lv, Shihong Cui, Xiao'an Zhang, Chenchen Ren
J Gynecol Oncol. 2020;31(2):e12.  Published online 2019 August 22    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e12
e13 Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
Se Ik Kim, Se Jeong Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim
J Gynecol Oncol. 2020;31(2):e13.  Published online 2019 August 22    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e13
e14 Tozzi classification of diaphragmatic surgery in patients with stage IIIC–IV ovarian cancer based on surgical findings and complexity
Roberto Tozzi, Federico Ferrari, Joost Nieuwstad, Riccardo Garruto Campanile, Hooman Soleymani Majd
J Gynecol Oncol. 2020;31(2):e14.  Published online 2019 September 2    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e14
e15 Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
Soo Jin Park, Jihye Kim, Hee Seung Kim, Jeong-Won Lee, Ha Kyun Chang, Keun Ho Lee, Dae-Yeon Kim, Sunghoon Kim, Suk-Joon Chang, Seung Su Han, Sang-Yoon Park, Seung-Hyuk Shim
J Gynecol Oncol. 2020;31(2):e15.  Published online 2019 September 10    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e15
e16 Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery
Jie Yang, Jiaxin Yang, Dongyan Cao, Keng Shen, Jiabin Ma, Fuquan Zhang
J Gynecol Oncol. 2020;31(2):e16.  Published online 2019 September 17    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e16
e19 Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
Moito Iijima, Noriyuki Okonogi, Nakako Izumi Nakajima, Yukie Morokoshi, Hiroaki Kanda, Taiju Yamada, Yusuke Kobayashi, Kouji Banno, Masaru Wakatsuki, Shigeru Yamada, Tadashi Kamada, Daisuke Aoki, Sumitaka Hasegawa
J Gynecol Oncol. 2020;31(2):e19.  Published online 2019 September 26    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e19
e20 Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis
Sasidharanpillai Sabeena, Santhosh Kuriakose, Binesh Damodaran, Nagaraja Ravishankar, Govindakarnavar Arunkumar
J Gynecol Oncol. 2020;31(2):e20.  Published online 2019 October 22    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e20
e22 Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study
Gitte Ørtoft, Claus Høgdall, Estrid S. Hansen, Margit Dueholm
J Gynecol Oncol. 2020;31(2):e22.  Published online 2019 October 4    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e22
e23 Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
Yoo-Na Kim, Yong Jae Lee, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
J Gynecol Oncol. 2020;31(2):e23.  Published online 2019 October 22    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e23
e43 Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
Ning Zhang, Hanjie Wang, Jili Yang
J Gynecol Oncol. 2020;31(2):e43.  Published online 2020 January 2    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e43
e44 In reply: the evaluation of IgG titers' stability from blood samples is necessary
Yung-Taek Ouh, Jae-Kwan Lee
J Gynecol Oncol. 2020;31(2):e44.  Published online 2020 January 28    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e44
e50 Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling
Yung-Taek Ouh, Kyung-Jin Min
J Gynecol Oncol. 2020;31(2):e50.  Published online 2020 January 17    DOI: http://dx.doi.org/10.3802/jgo.2020.31.e50
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology